» Articles » PMID: 33673728

Obesity Affects HDL Metabolism, Composition and Subclass Distribution

Abstract

Background: Obesity increases the risk of coronary heart disease, partly due to its strong association with atherogenic dyslipidemia, characterized by high triglycerides and low high-density lipoprotein (HDL) cholesterol levels. Functional impairment of HDL may contribute to the increased cardiovascular mortality, but the effect of obesity on composition, structure, and function of HDL is not well understood Design and Methods: We determined HDL composition, HDL subclass distribution, parameters of HDL function, and activities of most important enzymes involved in lipoprotein remodeling, including lecithin-cholesterol acyltransferase (LCAT) and cholesteryl ester transfer protein (CETP) in relatively young normal weight ( = 26), overweight ( = 22), and obese ( = 20) women.

Results: Obesity (body mass index (BMI) ≥ 30) was associated with noticeable changes in LCAT and CETP activities and altered HDL composition, such as decreased apolipoprotein A-I, cholesterol, and phospholipid content, while pro-inflammatory HDL serum amyloid a content was increased. We observed a marked shift towards smaller HDL subclasses in obesity linked to lower anti-oxidative capacity of serum. LCAT activity, HDL subclass distribution, and HDL-cholesterol were associated with soluble leptin receptor, adiponectin, and liver enzyme activities. Of note, most of these alterations were only seen in obese women but not in overweight women.

Conclusions: Obesity markedly affects HDL metabolism, composition, and subclass distribution linked to changes in liver and adipose tissue. HDL dysfunction may contribute to increased cardiovascular risk in obesity.

Citing Articles

Associations of excessive gestational weight gain with changes in components of maternal reverse cholesterol transport and neonatal outcomes.

Derikonjic M, Vekic J, Stefanovic A, Matutinovic M, Munjas J, Antonic T Sci Rep. 2025; 15(1):5716.

PMID: 39962221 PMC: 11832930. DOI: 10.1038/s41598-025-90168-z.


U-shaped association between the non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and mortality risk in obese adults: evidence from NHANES 1999-2018.

Lin Z, Yi T, Hu F, Chen J, Chen L Front Cardiovasc Med. 2025; 11:1524465.

PMID: 39866802 PMC: 11759299. DOI: 10.3389/fcvm.2024.1524465.


Interaction of genetics risk score and fatty acids quality indices on healthy and unhealthy obesity phenotype.

Rasaei N, Fatemi S, Gholami F, Samadi M, Keshavarz Mohammadian M, Daneshzad E BMC Med Genomics. 2025; 18(1):16.

PMID: 39838481 PMC: 11753101. DOI: 10.1186/s12920-024-02066-4.


Impact of metabolic-associated fatty liver disease on the cholesterol efflux capacity of high-density lipoproteins in adolescents with type 2 diabetes.

Orozco Morales J, Medina Urrutia A, Tamayo M, Reyes Barrera J, Galarza E, Juarez Rojas J Front Pediatr. 2025; 12():1462406.

PMID: 39776642 PMC: 11703661. DOI: 10.3389/fped.2024.1462406.


Effect of Diet on HDL in Obesity.

Bacchetti T, Morresi C, Simonetti O, Ferretti G Molecules. 2025; 29(24.

PMID: 39770044 PMC: 11677490. DOI: 10.3390/molecules29245955.


References
1.
Lorkowski S, Brubaker G, Rotroff D, Kashyap S, Bhatt D, Nissen S . Bariatric Surgery Improves HDL Function Examined by ApoA1 Exchange Rate and Cholesterol Efflux Capacity in Patients with Obesity and Type 2 Diabetes. Biomolecules. 2020; 10(4). PMC: 7226587. DOI: 10.3390/biom10040551. View

2.
Stadler J, Marsche G . Obesity-Related Changes in High-Density Lipoprotein Metabolism and Function. Int J Mol Sci. 2020; 21(23). PMC: 7731239. DOI: 10.3390/ijms21238985. View

3.
Oku H, Matsuura F, Koseki M, Sandoval J, Yuasa-Kawase M, Tsubakio-Yamamoto K . Adiponectin deficiency suppresses ABCA1 expression and ApoA-I synthesis in the liver. FEBS Lett. 2007; 581(26):5029-33. DOI: 10.1016/j.febslet.2007.09.038. View

4.
Magge S, Stettler N, Koren D, Katz L, Gallagher P, Mohler 3rd E . Adiponectin is associated with favorable lipoprotein profile, independent of BMI and insulin resistance, in adolescents. J Clin Endocrinol Metab. 2011; 96(5):1549-54. PMC: 3085202. DOI: 10.1210/jc.2010-2364. View

5.
Christou G, Kiortsis D . Adiponectin and lipoprotein metabolism. Obes Rev. 2013; 14(12):939-49. DOI: 10.1111/obr.12064. View